2-Iodopyridine | CAS:5029-67-4

We serve 2-Iodopyridine CAS:5029-67-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Iodopyridine

Chemical Name:2-Iodopyridine
CAS.NO:5029-67-4
Synonyms:2-Iodopyridine
Pyridine, 2-iodo-
2-Pyridyl iodide
 
Physical and Chemical Properties:
Density 2.0±0.1 g/cm3
Boiling Point 215.4±13.0 °C at 760 mmHg
Melting Point 118 – 120ºC
Molecular Formula C5H4IN
Molecular Weight 204.996
Flash Point 84.1±19.8 °C
 
Specification:
Appearance:Light yellow liquid
Assay:≥97.0%
Moisture:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-Iodopyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Pyridyl iodide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Pyridyl iodide Use and application,2-Iodopyridine technical grade,usp/ep/jp grade.


Related News: Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.2-Methyl-5-nitrophenol manufacturer Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”4-nitroheptanedial supplier What’s the background?4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate vendor Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities.Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.